D1R activation has shown improvement in hippocampal neurogenesis and anxiolytic and antidepressant-like effects in a rat model of PD, whereas the D1R antagonist SCH23390 was found to inhibit stimulant-induced DAR supersensitivity50. This evidence concerns the gene DRD1 and Parkinson disease.